Total Payments
$1,857
2024 Payments
$315.76
Companies
16
Transactions
26
Medicare Patients
5,098
Medicare Billing
$330,954
Payment Breakdown by Category
Food & Beverage$1,809 (97.4%)
Other$47.45 (2.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,809 | 25 | 97.4% |
| Entertainment | $47.45 | 1 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $359.35 | 4 | $0 (2018) |
| ABBVIE INC. | $242.77 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $171.24 | 2 | $0 (2020) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $139.40 | 2 | $0 (2018) |
| Shire North American Group Inc | $129.54 | 1 | $0 (2018) |
| GENZYME CORPORATION | $125.00 | 1 | $0 (2018) |
| Aerie Pharmaceuticals, Inc. | $116.14 | 1 | $0 (2019) |
| CooperVision Inc. | $93.19 | 1 | $0 (2024) |
| Spark Therapeutics, Inc. | $91.82 | 1 | $0 (2019) |
| Alcon Vision LLC | $81.33 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $315.76 | 5 | ABBVIE INC. ($119.43) |
| 2022 | $204.67 | 5 | ABBVIE INC. ($123.34) |
| 2021 | $24.82 | 1 | Kala Pharmaceuticals, Inc. ($24.82) |
| 2020 | $61.55 | 1 | Novartis Pharmaceuticals Corporation ($61.55) |
| 2019 | $255.41 | 3 | Aerie Pharmaceuticals, Inc. ($116.14) |
| 2018 | $643.93 | 7 | Bausch & Lomb, a division of Bausch Health US, LLC ($139.40) |
| 2017 | $350.71 | 4 | Allergan Inc. ($241.02) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/07/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/13/2024 | CooperVision Inc. | MiSight Contact Lens (Device) | Food and Beverage | In-kind items and services | $93.19 | General |
| Category: Devices | ||||||
| 10/12/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 03/21/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $119.43 | General |
| Category: EYE CARE | ||||||
| 03/14/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $67.50 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/07/2022 | Alcon Vision LLC | ARGOS (Device) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Ophthalmology | ||||||
| 06/28/2022 | ABBVIE INC. | VUITY (Drug) | Food and Beverage | In-kind items and services | $123.34 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/19/2022 | Alcon Vision LLC | ARGOS (Device) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Ophthalmology | ||||||
| 02/08/2022 | Alcon Vision LLC | ARGOS (Device) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Ophthalmology | ||||||
| 02/02/2022 | Alcon Vision LLC | ARGOS (Device) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: Ophthalmology | ||||||
| 08/13/2021 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug), EYSUVIS | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Ocular | ||||||
| 02/05/2020 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $61.55 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/04/2019 | OPTOS, INC. | P200DTx (Device), P200T, P200TE | Entertainment | Cash or cash equivalent | $47.45 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/24/2019 | Spark Therapeutics, Inc. | LUXTURNA (Biological) | Food and Beverage | In-kind items and services | $91.82 | General |
| Category: OCULAR | ||||||
| 05/08/2019 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug), Rocklatan | Food and Beverage | In-kind items and services | $116.14 | General |
| Category: Glaucoma | ||||||
| 11/02/2018 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $72.02 | General |
| Category: Ophthalmology | ||||||
| 10/23/2018 | Allergan Inc. | — | Food and Beverage | In-kind items and services | $118.33 | General |
| 09/26/2018 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $129.54 | General |
| Category: OPTHALMICS | ||||||
| 06/18/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | BTOD (Device), ULTRA | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/23/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $113.36 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/01/2018 | Visioneering Technologies, Inc. | — | Food and Beverage | Cash or cash equivalent | $59.64 | General |
| 01/30/2018 | GENZYME CORPORATION | CEREZYME (Drug), FABRAZYME, ALDURAZYME | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RARE DISEASE GENETICS | ||||||
| 06/28/2017 | Novartis Pharmaceuticals Corporation | SIMBRINZA (Biological) | Food and Beverage | In-kind items and services | $109.69 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/22/2017 | Allergan Inc. | — | Food and Beverage | In-kind items and services | $99.20 | General |
| 03/26/2017 | Allergan Inc. | — | Food and Beverage | In-kind items and services | $16.35 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 1,284 | 1,536 | $247,380 | $83,942 |
| 2022 | 8 | 1,308 | 1,564 | $230,055 | $81,739 |
| 2021 | 8 | 1,296 | 1,551 | $227,055 | $88,284 |
| 2020 | 8 | 1,210 | 1,381 | $204,040 | $76,987 |
Total Patients
5,098
Total Services
6,032
Medicare Billing
$330,954
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 548 | 627 | $120,435 | $48,547 | 40.3% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 157 | 218 | $30,890 | $12,404 | 40.2% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 164 | 197 | $23,640 | $8,175 | 34.6% |
| 92133 | Imaging of optic nerve | Office | 2023 | 175 | 224 | $31,360 | $5,076 | 16.2% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 59 | 59 | $12,945 | $4,645 | 35.9% |
| 92134 | Imaging of retina | Office | 2023 | 118 | 148 | $20,720 | $3,979 | 19.2% |
| 92250 | Photography of the retina | Office | 2023 | 50 | 50 | $7,000 | $1,017 | 14.5% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 13 | 13 | $390.00 | $99.72 | 25.6% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 527 | 602 | $99,330 | $44,219 | 44.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 159 | 215 | $26,875 | $12,374 | 46.0% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 157 | 196 | $23,520 | $7,890 | 33.5% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 86 | 86 | $16,770 | $6,835 | 40.8% |
| 92133 | Imaging of optic nerve | Office | 2022 | 161 | 213 | $29,820 | $4,583 | 15.4% |
| 92134 | Imaging of retina | Office | 2022 | 133 | 162 | $22,680 | $3,990 | 17.6% |
| 92250 | Photography of the retina | Office | 2022 | 71 | 76 | $10,640 | $1,754 | 16.5% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2022 | 14 | 14 | $420.00 | $93.91 | 22.4% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 510 | 579 | $95,535 | $45,715 | 47.9% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 175 | 248 | $31,000 | $15,160 | 48.9% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 84 | 84 | $16,380 | $8,425 | 51.4% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 140 | 185 | $22,200 | $7,979 | 35.9% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 149 | 195 | $27,300 | $4,418 | 16.2% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 131 | 149 | $20,860 | $4,116 | 19.7% |
| 92250 | Photography of the retina | Office | 2021 | 91 | 95 | $13,300 | $2,332 | 17.5% |
| 76514 | Ultrasound of corneal structure and measurement | Office | 2021 | 16 | 16 | $480.00 | $139.62 | 29.1% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 539 | 594 | $98,010 | $45,256 | 46.2% |
About Dr. Paul Westfall, O.D
Dr. Paul Westfall, O.D is a Optometrist healthcare provider based in Glens Falls, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831103464.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Westfall, O.D has received a total of $1,857 in payments from pharmaceutical and medical device companies, with $315.76 received in 2024. These payments were reported across 26 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,809).
As a Medicare-enrolled provider, Westfall has provided services to 5,098 Medicare beneficiaries, totaling 6,032 services with total Medicare billing of $330,954. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Optometrist
- Other Specialties Corneal and Contact Management, Low Vision Rehabilitation
- Location Glens Falls, NY
- Active Since 07/28/2006
- Last Updated 11/08/2016
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1831103464
Products in Payments
- XIIDRA (Drug) $191.09
- RESTASIS (Drug) $125.47
- CEREZYME (Drug) $125.00
- VUITY (Drug) $123.34
- LUMIGAN (Drug) $119.43
- Rhopressa (Drug) $116.14
- VYZULTA (Drug) $113.36
- SIMBRINZA (Biological) $109.69
- MiSight Contact Lens (Device) $93.19
- LUXTURNA (Biological) $91.82
- ARGOS (Device) $81.33
- Lucentis (Biological) $72.02
- TEPEZZA (Biological) $67.50
- P200DTx (Device) $47.45
- XDEMVY (Drug) $35.64
- BTOD (Device) $26.04
- INVELTYS (Drug) $24.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Glens Falls
Dr. Carolee Boyd, O.d, O.D
Optometrist — Payments: $4,427
Optometrist $4,427
Dr. Dawn Chivers, O.d, O.D
Optometrist — Payments: $3,853
Optometrist $3,853
Dr. Kamaljit Westfall, O.d, O.D
Optometrist — Payments: $1,631
Optometrist $1,631
Dr. Enrique Yepes-Hoyos, Od, OD
Optometrist — Payments: $1,358
Optometrist $1,358
Dr. Jeffrey Jarett, Od, OD
Optometrist — Payments: $495.71
Optometrist $495.71
Dr. Terry Walton, O.d, O.D
Optometrist — Payments: $342.79
Optometrist $342.79